Document Detail


ACOG Committee Opinion No. 458: Hysterosalpingography after tubal sterilization.
MedLine Citation:
PMID:  20502313     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The U.S. Food and Drug Administration has approved two devices for hysteroscopic tubal sterilization. To minimize the failure rates of these effective methods, it is important for health care providers to understand the important role hysterosalpingography (HSG) plays in any hysteroscopic tubal sterilization procedure. The purpose of this Committee Opinion is to emphasize the necessity of performing HSG 3 months after hysteroscopic tubal sterilization and to identify factors that may interfere with performance of an adequate HSG assessment.
Authors:
Related Documents :
8625033 - The roles and functions of hospital-based ethics committees.
8000833 - European society of mastology consensus conference on breast cancer screening: report o...
19492723 - Practice and evaluation of ethical governance in assisted reproductive technologies.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  115     ISSN:  1873-233X     ISO Abbreviation:  Obstet Gynecol     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-26     Completed Date:  2010-07-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1343-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Endometrial Ablation Techniques / contraindications*
Equipment Failure Analysis
Female
Humans
Hysterosalpingography*
Prostheses and Implants*
Sterilization, Tubal / instrumentation*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Committee opinions no. 457: preparing for disasters: perspectives on women.
Next Document:  Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Ugand...